financetom
Business
financetom
/
Business
/
Hoka-parent Deckers Outdoor's forecast disappoints despite solid holiday quarter
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hoka-parent Deckers Outdoor's forecast disappoints despite solid holiday quarter
Jan 30, 2025 2:43 PM

(Reuters) -Deckers Outdoor on Thursday beat third-quarter sales estimates on robust holiday demand for its Hoka running shoes, but an in-line annual forecast caused the footwear maker's shares to tumble 17% in extended trading.

Hoka shoes with their oversized soles have been gaining market share from brands such as Nike in the sportswear category. The brand, which retails for up to $300 in the United States, have also enjoyed full-price sales.

This drove up the company's third-quarter revenue by 17% to $1.83 billion, beating analysts' average estimate of $1.73 billion, according to data compiled by LSEG. Deckers also raised its annual net sales forecast for a second time this year.

"The guidance looks pretty conservative and considering the beat, it's bit of a negative read into the out quarter," said Drake MacFarlane, analyst at MScience.

The popularity of the Hoka shoes and the success of the company's UGG boots and sandals has helped it post double-digit revenue growth for nearly seven quarters.

The company now expects annual net sales to increase about 15% to $4.9 billion, compared with its prior expectation of about 12% growth to $4.8 billion. Analysts estimated an increase of 14.9% to $4.93 billion.

Deckers expects annual earnings per share of $5.75 to $5.80, compared with its prior forecast of $5.15 to $5.25.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lineage Cell Therapeutics Partners With William Demant Invest to Develop Hearing Loss Treatment
Lineage Cell Therapeutics Partners With William Demant Invest to Develop Hearing Loss Treatment
Aug 26, 2025
08:56 AM EDT, 08/26/2025 (MT Newswires) -- Lineage Cell Therapeutics ( LCTX ) said Tuesday that it has partnered with William Demant Invest to jointly develop the company's ReSonance auditory neuronal cell transplant for hearing loss treatment. William Demant Invest will invest up to $12 million in development costs, Lineage said. The company said that the multi-year research partnership will...
Sector Update: Consumer
Sector Update: Consumer
Aug 26, 2025
08:58 AM EDT, 08/26/2025 (MT Newswires) -- Consumer stocks were steady pre-bell Tuesday, with the Consumer Staples Select Sector SPDR Fund (XLP) slightly increasing and the Consumer Discretionary Select Sector SPDR Fund (XLY) inactive. Atour Lifestyle Holdings ( ATAT ) shares were up more than 5% after the company posted higher Q2 adjusted earnings and revenue. ...
IperionX Receives Additional $12.5 Million Under Pentagon Contract
IperionX Receives Additional $12.5 Million Under Pentagon Contract
Aug 26, 2025
08:55 AM EDT, 08/26/2025 (MT Newswires) -- IperionX ( IPX ) said Tuesday the US Department of Defense has obligated $12.5 million under its previously announced $47.1 million award to accelerate the scale-up of a US mineral-to-metal titanium supply chain. The $12.5 million will be applied to purchase orders for major capital equipment required for capacity scale-up to over 1,000...
Wedbush Downgrades Verint Systems to Neutral From Outperform Following Thoma Bravo Takeover, Maintains $20.50 Price Target
Wedbush Downgrades Verint Systems to Neutral From Outperform Following Thoma Bravo Takeover, Maintains $20.50 Price Target
Aug 26, 2025
08:59 AM EDT, 08/26/2025 (MT Newswires) -- Verint Systems ( VRNT ) has an average rating of hold and mean price target of $20.50, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved